Pharmaceuticals in Canada - Market Summary, Competitive Analysis and Forecast, 2016-2025
Summary Pharmaceuticals in Canada industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value and volume 2016-20, and forecast to 2025). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
Key Highlights - The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare. - The Canadian pharmaceuticals market had total revenues of $20.2bn in 2020, representing a compound annual growth rate (CAGR) of 1.3% between 2016 and 2020. - The launch of the Biosimilars Initiative in many provinces in Canada is likely to significant impact market growth as physicians are obliged to prescribe this cheaper alternative where possible. - The Canadian government plans to regulate the cost of prescription drugs to generate savings of $10bn over the next ten years for Canadian citizens. If successful, this could contribute to a slowdown in growth anticipated in the market over the forecast period.
Scope - Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the pharmaceuticals market in Canada - Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pharmaceuticals market in Canada - Leading company profiles reveal details of key pharmaceuticals market players’ global operations and financial performance - Add weight to presentations and pitches by understanding the future growth prospects of the Canada pharmaceuticals market with five year forecasts by both value and volume
Reasons to Buy - What was the size of the Canada pharmaceuticals market by value in 2020? - What will be the size of the Canada pharmaceuticals market in 2025? - What factors are affecting the strength of competition in the Canada pharmaceuticals market? - How has the market performed over the last five years? - Who are the top competitors in Canada’s pharmaceuticals market?
Our reports have been used by over 10K customers, including:
Acute Respiratory Distress Syndrome Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary This latest Pharmaceutical and Healthcare disease pipeline guide Acute Respiratory Distress Syndrome - Drugs in Development by Stages, Target, MoA, RoA, Molecule...
Tyrosine Protein Kinase JAK2 (Janus Kinase 2 or JAK2 or EC 2.7.10.2) Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary Tyrosine Protein Kinase JAK2 (Janus Kinase 2 or JAK2 or EC 2.7.10.2) - Janus kinase 2 is a non-receptor tyrosine...
Proto Oncogene Tyrosine Protein Kinase Src (Proto Oncogene c Src or pp60c src or SRC or EC 2.7.10.2) Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary According to the recently published report ’Proto Oncogene Tyrosine Protein Kinase...
400 pages •
By The Business Research Company
• Mar 2022
Major players in the pharmaceutical sterility testing market are Pacific Biolabs, STRERIS Corporation, Boston Analytical, Gibraltar Laboratories, Sartorius AG, SolviasAG, SGS AG, Toxikon Inc., Pace Analytical Services LLC, Charles River Laboratories International Inc, Nelson Laboratories Inc, Rapid Micro Biosystems Inc., BioMerieux, Merck...
The chromatography resin market is estimated to grow to USD 3.8 billion by 2027 from USD 2.6 billion in 2022, at a CAGR of 8.0%. Chromatography is one of the most used analytical techniques in the quality testing and quality control of processed food products and various beverages. According to World Health Organization, food contamination...
240 pages •
By Asia Market Information & Development Company
• May 2022
China’s demand for Genome-Based Drug has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, import & export, consumer consumption...
Bronchopulmonary Dysplasia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary This latest Pharmaceutical and Healthcare disease pipeline guide Bronchopulmonary Dysplasia - Drugs In Development, 2022, provides an overview of the Bronchopulmonary Dysplasia...
The Global Pharmaceutical Contract Manufacturing Organization (CMO) Market was valued at USD 134.12 billion in 2021, and it is expected to reach USD 204.14 billion by 2027, registering a CAGR of 6.64% from 2022 to 2027. As a result of the rising demand for generic medicines and biologics, the capital-intensive nature of the business, and the...
Myasthenia Gravis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary This latest Pharmaceutical and Healthcare disease pipeline guide Myasthenia Gravis - Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update,...
Pharmaceutical
Therapy
China
Drug Approval
Practising Nurses And Midwives
By continuing to use this site you consent to the use of cookies on your device as described in our Cookie Policy unless you have disabled them.
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.